NUVASIVE MLX ? MEDIAL LATERAL EXPANDABLE LUMBAR INTERBODY SYSTEM NUVASIVE AP

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,study report with the FDA on 2020-03-18 for NUVASIVE MLX ? MEDIAL LATERAL EXPANDABLE LUMBAR INTERBODY SYSTEM NUVASIVE AP manufactured by Nuvasive, Incorporated.

Event Text Entries

[188118239] No product has been returned for evaluation nor were radiographs or images provided to confirm the alleged event. It is unknown if patient followed post-operative restrictions or suffered a fall. Patient's bone quality is unknown. Labeling review: "... As with any major surgical procedures, there are risks involved in orthopedic surgery. Infrequent operative and postoperative complications that may result in the need for additional surgeries include: potential risks identified with the use of this system, which may require additional surgery, include: bending, fracture or loosening of implant component(s)? " warnings, cautions and precautions "... Correct selection of the implant is extremely important. The potential for success is increased by the selection of the proper size of the implant. While proper selection can minimize risks, the size and shape of human bones present limitations on the size and strength of implants. Metallic internal fixation devices cannot withstand the activity levels and/or loads equal to those placed on normal, healthy bone. These devices are not designed to withstand the unsupported stress of full weight or load bearing alone... " post-operative warnings "... During the postoperative phase it is of particular importance that the physician keeps the patient well informed of all procedures and treatments. Damage to the weight-bearing structures can give rise to loosening of the components, dislocation and migration as well as to other complications... "
Patient Sequence No: 1, Text Type: N, H10


[188118240] On (b)(6) 2018, patient underwent an l5-s1 transforaminal lumbar interbody fusion. On (b)(6) 2018 the patient reported to the emergency room radicular symptoms and severe pain in the foot. Radiographs revealed a lateral vertebral body fracture and subsidence at l5 level. On (b)(6) 2018 an exploration procedure was performed and scar tissue, ligament and synovium at l5 was discovered. No revision procedure of the vertebral body was reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2031966-2020-00044
MDR Report Key9851251
Report SourceCOMPANY REPRESENTATIVE,STUDY
Date Received2020-03-18
Date of Report2020-03-10
Date of Event2018-03-21
Date Mfgr Received2020-02-25
Date Added to Maude2020-03-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMISS VIRNALISA COBACHA
Manufacturer Street7475 LUSK BLVD
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal92121
Manufacturer G1NUVASIVE, INCORPORATED
Manufacturer Street7475 LUSK BLVD
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal Code92121
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNUVASIVE MLX ? MEDIAL LATERAL EXPANDABLE LUMBAR INTERBODY SYSTEM NUVASIVE AP
Generic NameINTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT, LUMBAR
Product CodeMAX
Date Received2020-03-18
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerNUVASIVE, INCORPORATED
Manufacturer Address7475 LUSK BLVD SAN DIEGO CA 92121 US 92121


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2020-03-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.